Baxter International Stock
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people.
About Baxter International Stock
Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.
Management
Senior Manager, International Pricing & Tender Strategy
Richard Waygood
Corporate Vice President and Chief Financial Officer
James K. Saccaro
Corporate Officers
Brik V. Eyre
Executive Officers
Robert J. Hombach
CIO, Baxter Healthcare
John Parker
Global Chief Privacy Officer
Abhishek Agarwal
Executive Officers
David P. Scharf
Executive Officers
Phillip L. Batchelor
Corporate Officers
Mary Kay Ladone
Bristol - Myers Squibb
Ana Koenig
Press
Connecting Yourself to "Value/s"
Forbes - Dec, 6 2019
Edwards Lifesciences Would Make Peter Drucker Smile
Forbes - Nov, 29 2019
A Canadian Citizen Held in Syrian Prisons is Set Free
New York Times - Aug, 9 2019
Facebook Board to Tighten Oversight, as Zuckerberg Keeps Control
Wall Streets Journal - Jul, 24 2019
Shutdown's Latest Victim: Hundreds Of Delayed Lifesaving Medical Devices
Forbes - Jan, 24 2019
Dan Loeb Sells Baxter International Shares At Strong Gain
Forbes - Dec, 6 2018
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Baxter International or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
